Free database of papers and journals

Results 1 to 20 of 66 articles found

Hydroxychloroquine in systemic lupus erythematosus

Lancet (9.3 902★★★), 369, 1257-1258.

Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?

Autoimmunity Reviews (7.8 131), 14, 23-29.

Hydroxychloroquine: A multifaceted treatment in lupus

La Presse Médicale (0.2 37), 43, e167-e180.

Low Blood Concentration of Hydroxychloroquine in Patients With Refractory Cutaneous Lupus Erythematosus

Archives of Dermatology (189), 148, 479.

Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases

Annals of the Rheumatic Diseases (6.9 256★★), 66, 1547-1548.

Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation


Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood

Future Science OA (2.4 31), 1, .

Hydroxychloroquine-Induced Pigmentation in Patients With Systemic Lupus Erythematosus

JAMA Dermatology (3 76★★), 149, 935.

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature

Autoimmunity Reviews (7.8 131), 4, 111-115.

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

Annals of the Rheumatic Diseases (6.9 256★★), 72, 1786-1792.

Routine Hydroxychloroquine Blood Concentration Measurement in Systemic Lupus Erythematosus Reaches Adulthood

Journal of Rheumatology (2.7 98), 42, 1997-1999.

Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus

Annals of the Rheumatic Diseases (6.9 256★★), 66, 821-824.

[Communication] Evidence of transplacental passage of hydroxychloroquine in humans

Arthritis and Rheumatism (365), 46, 1123-1124.

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Annals of the Rheumatic Diseases (6.9 256★★), 80, 1.1-2.

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

Arthritis & Rheumatology (6.4 108), 67, 2176-2184.

[Communication] Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: Comment on the article by Koneru et al

Arthritis and Rheumatism (365), 59, 153-153.

The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study

Journal of the American Academy of Dermatology (1.3 253★★), 74, 693-699.e3.

[Communication] Different Control Populations May Lead to Different Understanding of Hydroxychloroquine Blood Levels as a Risk Factor for Retinopathy: Comment on the Article by Petri et al

Arthritis & Rheumatology (6.4 108), 73, 715-715.

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty-three cases compared with a control group

Arthritis and Rheumatism (365), 48, 3207-3211.

Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence

Arthritis Research & Therapy (4.2 134), 22, .
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor